Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia [Phase 3]
A Phase 3 clinical trial evaluating NBI-1117568 in inpatient adults with schizophrenia is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Enhancing Veteran-Clinical Collaboration in VA PRRCs [NA]
A VA-sponsored initiative aims to enhance veteran-clinical collaboration within VA PRRCs; the study is currently not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Cognitive Strategies in Early Psychosis 2 [Phase 3]
A Phase 3 clinical trial from the University of Minnesota evaluating cognitive strategies in early psychosis, currently not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia [Phase 3]
A Phase 3 clinical trial evaluating NBI-1117568 for preventing relapse in adults with schizophrenia is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Evaluation of NBI-1117570 in Inpatient Adults With Schizophrenia [Phase 2]
Phase 2 clinical trial update indicates that NBI-1117570 is being evaluated in inpatient adults with schizophrenia and is currently recruiti…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia [Phase 3]
This clinical trial update indicates that a Phase 3 long-term study of NBI-1117568 for adults with schizophrenia is currently recruiting. No…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Effect of Curcumin Add-On Therapy on Quality of Life and IL-1β Levels in Patients With Schizophrenia [NA]
A completed clinical trial evaluated curcumin as add-on therapy for schizophrenia, examining quality of life and IL-1β levels.
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Risk of Breakthrough Symptoms With Long-Acting Injectable Medications
This completed clinical trial update reports on the risk of breakthrough symptoms associated with long-acting injectable antipsychotics in p…
-
FDA approval · 2026-04-13FDA Approved: LURASIDONE HYDROCHLORIDE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approves Torrent Pharmaceuticals Limited's supplemental application for lurasidone hydrochloride, signifying an update to the product's …
-
EMA approval · 2026-04-13EMA Authorised: Aripiprazole Sandoz (aripiprazole) — Sandoz GmbH
The European Medicines Agency authorised Aripiprazole Sandoz (aripiprazole) by Sandoz GmbH for treating schizophrenia and bipolar disorder.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia [Phase 3]
A Phase 3 clinical trial evaluating LB-102 for acute schizophrenia is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
A clinical trial update for the KarXT combination (Xanomeline and Trospium Chloride) evaluating effectiveness and adverse-effect switching i…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Phase II Clinical Study to Evaluate the Efficacy and Safety of NS-136 in the Treatment of Schizophrenia [Phase 2]
This document provides an update on an ongoing Phase II trial evaluating NS-136 for acute schizophrenia, including enrollment status and stu…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: "Extended" (Alternate Day) Antipsychotic Dosing [Phase 4]
Phase 4 clinical trial update evaluating extended (alternate-day) dosing of an antipsychotic for schizophrenia; the study is currently recru…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Accelerated Transcranial Magnetic Stimulation for People With Schizophrenia Treated With Clozapine [NA]
The study investigates accelerated transcranial magnetic stimulation as a treatment option for people with schizophrenia who are being treat…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
A registered clinical registry evaluating treatment satisfaction and KarXT utilization in schizophrenia, currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder [Phase 1]
A Phase 1 clinical trial evaluating BXCL501 for efficacy and safety in agitation associated with pediatric schizophrenia and related disorde…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A PET/MRI Study of Cobenfy on Dopamine Transmission in Schizophrenia [Phase 1, Phase 2]
A Phase 1/2 PET/MRI study of Cobenfy assessing dopamine transmission in schizophrenia and schizoaffective disorder, currently not yet recrui…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Paired Associative Stimulation in the Dorsolateral Prefrontal Cortex in Patients With Schizophrenia [NA]
This clinical trial update notes the status of a study evaluating paired associative stimulation of the dorsolateral prefrontal cortex in pa…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: 52-week Open Label Safety-Tolerability Study [Phase 3]
LB Pharmaceuticals Inc. announced a 52-week open-label safety and tolerability study in schizophrenia patients (Phase 3), which is not yet r…
-
EMA approval · 2026-04-08EMA Authorised: Aripiprazole Zentiva (aripiprazole) — Zentiva, k.s.
The EMA has authorised Aripiprazole Zentiva (aripiprazole) for the treatment of schizophrenia and bipolar disorder. The marketing authorizat…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: A Study to Test Long-term Safety of Iclepertin in People With Schizophrenia Who Took Part in a Previous CONNEX Study [Phase 3]
Phase 3 long-term safety study of Iclepertin in schizophrenia participants has been terminated, with results posted.
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Functional Relevance of Dopamine Receptors in Healthy Controls and Patients With Schizophrenia: Characterization Through [11C]NNC-112 and [18F]Fallypride Positron Emission Tomography
Completed clinical trial evaluating dopamine receptor function in healthy controls and patients with schizophrenia and schizoaffective disor…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Long-acting Injectable Antipsychotics for Mental Ill-Health in Pregnancy and Postpartum
A completed clinical trial update from the University of Liverpool evaluating long-acting injectable antipsychotics for mental ill-health du…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN) [Phase 3]
This clinical trial update announces a Phase 3 study (EMERGENT TEEN) evaluating KarXT for schizophrenia in adolescents, with recruitment cur…